טוען...
Prognostic impact of carbohydrate antigen 19-9 level at diagnosis in resected stage I–III pancreatic adenocarcinoma: a U.S. population study
BACKGROUND: Pancreatic adenocarcinoma is a highly aggressive cancer, with surgical resection and systemic therapy offering the only hope for long-term survival. Carbohydrate antigen 19-9 (CA 19-9) has been used as a prognostic marker after resection; however, the relationship between survival and pr...
שמור ב:
| הוצא לאור ב: | J Gastrointest Oncol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
AME Publishing Company
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5674264/ https://ncbi.nlm.nih.gov/pubmed/29184681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.07.04 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|